Transcept Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Transcept Pharmaceuticals, Inc.
SELUTION SLR is the first drug-eluting balloon accepted by the FDA as part of its breakthrough program, according to the company.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
The Swiss company is rolling out the sirolimus-eluting balloon catheter in Europe and sponsoring trials in the US. The FDA has granted it breakthrough status for three different indications.
Private Company Edition: Nkarta, Passage Bio and Achilles kicked off September with VC deals totaling more than $100m each. Also, Repare raised $82.5m and SutroVax won CARB-X cash.
- Drug Delivery
- Other Names / Subsidiaries
- Novacea, Inc.
- TransOral Pharmaceuticals, Inc.